🔗 Permalink

Assignee profile:

CIMA LABS INC.

City:

Brooklyn Park, Minnesota

Country:

United States

Published Applications:

Last publication date:

2017-05-25

Patent Grants:

Last grant date:

2019-02-12

Top Inventors for applications by CIMA LABS INC.

These are the the leading inventors for applications assigned to CIMA LABS INC.:

Manuel A. Vega Zepeda 7 Minnetonka, MN United States
Ehab Hamed 6 Concord, MA United States
Victoria A. O'Neill 4 Wayzata, MN United States
Dinesh K. Haswani 4 Plymouth, MN United States

Derek V. Moe 4 Mound, MN United States
Ehab Hamed 3 Maple Grove, MN United States
Walid A. Habib 2 Maple Grove, MN United States
Randal A. Seburg 2 Maple Grove, MN United States

Walid Habib 2 Brooklyn Park, MN United States
Ehab Hamed 2 Brooklyn Park, MN United States
Carrie Kraling 2 Brooklyn Park, MN United States
Manuel A. Vega Zepeda 2 Minneapolis, MN United States

Derek Moe 2 Brooklyn Park, MN United States
Lisa Hillman 2 Brooklyn Park, MN United States
Cima Labs Inc. 2 Brooklyn Park, MN United States
Carrie Kraling 1 Minneapolis, MN United States

Bhaveshkumar Kothari 1 Smithtown, NY United States
Walid A. Habib 1 Riyadh, Saudi Arabia
Michelle Nivala 1 St. Paul, MN United States
Walid Habib 1 Maple Grove, MN United States

Recent patent applications by CIMA LABS INC.

CIMA LABS INC. based in Brooklyn Park, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-05-25 ✅ Patent 10,201,505 granted on 2019-02-12

US20170143637A1

Human necessities

Immediate release abuse-deterrent granulated dosage forms

#2 | 2016-11-03 ✅ Patent 9,827,204 granted on 2017-11-28

US20160317457A1

Human necessities

Immediate release abuse-deterrent granulated dosage forms

#3 | 2015-09-10 ✅ Patent 9,216,176 granted on 2015-12-22

US20150250730A1

Human necessities

Abuse resistant drug formulation

#4 | 2015-04-30 ✅ Patent 9,757,371 granted on 2017-09-12

US20150118303A1

Human necessities

Immediate release abuse-deterrent granulated dosage forms

#5 | 2015-04-30 ✅ Patent 9,707,224 granted on 2017-07-18

US20150118302A1

Human necessities

Immediate release abuse-deterrent granulated dosage forms

#6 | 2014-10-02 ✅ Patent 9,474,721 granted on 2016-10-25

US20140294953A1

Human necessities

Abuse-resistant formulations

#7 | 2013-10-10 ✅ Patent 8,927,025 granted on 2015-01-06

US20130266660A1

Human necessities

Alcohol-resistant metoprolol-containing extended-release oral dosage forms

#8 | 2013-08-15

US20130209560A1

Human necessities

ABUSE-RESISTANT FORMULATIONS

#9 | 2013-08-08

US20130202705A1

Human necessities

ALCOHOL-RESISTANT FORMULATIONS

#10 | 2013-07-04

US20130171256A1

Human necessities

ALCOHOL-RESISTANT EXTENDED RELEASE DOSAGE FORMS COMPRISING VENLAFAXINE

#11 | 2013-05-16 ✅ Patent 9,572,803 granted on 2017-02-21

US20130122101A1

Human necessities

Abuse resistant drug formulation

#12 | 2013-05-16 ✅ Patent 9,974,751 granted on 2018-05-22

US20130122087A1

Human necessities

Abuse resistant drug formulation

#13 | 2012-09-06

US20120225122A1

Human necessities

Abuse-Resistant Formulations

#14 | 2011-08-18

US20110200681A1

Human necessities

Abuse Resistant Drug Formulation

#15 | 2008-12-18 ✅ Patent 8,445,018 granted on 2013-05-21

US20080311205A1

Human necessities

Abuse resistant drug formulation

#16 | 2007-12-06 ✅ Patent 8,637,076 granted on 2014-01-28

US20070281013A1

Human necessities

Prednisolone salt formulations

#17 | 2006-12-21 ✅ Patent 8,191,711 granted on 2012-06-05

US20060283759A1

Performing operations; transporting

Bend and peel tablet package

Also check out CIMA LABS INC.'s (Brooklyn Park, United States) applicant profile with 8 patent applications submitted.

AssigneeID:

22808 ⎘